DJ Catalyst Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Catalyst Pharmaceuticals Inc. (CPRX) rose 2.89% to $21.73 Monday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.95% to 21,053.58 and the Dow Jones Industrial Average rising 1.34% to 44,173.64.
Catalyst Pharmaceuticals Inc. closed 18.25% short of its 52-week high of $26.58, which the company achieved on June 9th.
The stock outperformed some of its competitors Monday, as Johnson & Johnson $(JNJ)$ rose 2.22% to $171.04, Pfizer Inc. $(PFE.AU)$ rose 0.17% to $23.53, and Abbott Laboratories $(ABT.AU)$ rose 2.07% to $129.93.
Trading volume (889,728) remained 388,558 below its 50-day average volume of 1.3 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 4, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
August 04, 2025 17:23 ET (21:23 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。